Citation Impact
Citing Papers
Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro
2006 StandoutNobel
Neutralizing antibody response during acute and chronic hepatitis C virus infection
2004 StandoutNobel
Complete Replication of Hepatitis C Virus in Cell Culture
2005 StandoutScienceNobel
Crippling life support for SARS-CoV-2 and other viruses through synthetic lethality
2020 StandoutNobel
Mouse models of acute and chronic hepacivirus infection
2017 StandoutScienceNobel
Production of Infectious Genotype 1b Virus Particles in Cell Culture and Impairment by Replication Enhancing Mutations
2009
Ultrastructural organisation of HCV from the bloodstream of infected patients revealed by electron microscopy after specific immunocapture
2016
Current progress in development of hepatitis C virus vaccines
2013
Cellular Binding of Hepatitis C Virus Envelope Glycoprotein E2 Requires Cell Surface Heparan Sulfate
2003
Identification and Targeting of an Interaction between a Tyrosine Motif within Hepatitis C Virus Core Protein and AP2M1 Essential for Viral Assembly
2012
Characterization of Hepatitis C Virus Particle Subpopulations Reveals Multiple Usage of the Scavenger Receptor BI for Entry Steps
2012
Quantitative Proteomic Analysis of Host-virus Interactions Reveals a Role for Golgi Brefeldin A Resistance Factor 1 (GBF1) in Dengue Infection
2014
Maturation of secreted HCV particles by incorporation of secreted ApoE protects from antibodies by enhancing infectivity
2017
Pan-Genotype Hepatitis E Virus Replication in Stem Cell–Derived Hepatocellular Systems
2017 StandoutNobel
Human pluripotent stem cell-derived hepatocytes support complete replication of hepatitis C virus
2012
MAP-Kinase Regulated Cytosolic Phospholipase A2 Activity Is Essential for Production of Infectious Hepatitis C Virus Particles
2012
Early steps of the hepatitis C virus life cycle
2008
Inflammation and cancer
2002 StandoutNature
SEC14L2 enables pan-genotype HCV replication in cell culture
2015 StandoutNatureNobel
Completion of the entire hepatitis C virus life cycle in genetically humanized mice
2013 StandoutNatureNobel
Hepatitis C virus E1 envelope glycoprotein interacts with apolipoproteins in facilitating entry into hepatocytes
2011
Hepatitis C virus—host interactions, replication, and viral assembly
2012
Molecular Determinants and Dynamics of Hepatitis C Virus Secretion
2012
Human ADAR1 Prevents Endogenous RNA from Triggering Translational Shutdown
2018 StandoutNobel
Unravelling hepatitis C virus replication from genome to function
2005 StandoutNatureNobel
Hepatitis C Virus p7 is Critical for Capsid Assembly and Envelopment
2013
Interaction of hepatitis C virus proteins with host cell membranes and lipids
2002
Cell Entry of Hepatitis C Virus Requires a Set of Co-receptors That Include the CD81 Tetraspanin and the SR-B1 Scavenger Receptor
2003
Developments in Quantitative PCR
1998
Regulation of hepatic innate immunity by hepatitis C virus
2013
Morphology and Molecular Composition of Purified Bovine Viral Diarrhea Virus Envelope
2016
High Density Lipoproteins Facilitate Hepatitis C Virus Entry through the Scavenger Receptor Class B Type I
2005
Host neutralizing responses and pathogenesis of hepatitis C virus infection†
2008
A new mathematical model for relative quantification in real-time RT-PCR
2001 Standout
Hepatitis C Virus RNA Replication
2013
Identification of the Niemann-Pick C1–like 1 cholesterol absorption receptor as a new hepatitis C virus entry factor
2012
Steatosis and hepatitis C virus: Mechanisms and significance for hepatic and extrahepatic disease
2004
microRNA-122 stimulates translation of hepatitis C virus RNA
2008
HCV E2 core structures and mAbs: something is still missing
2014
Hepatitis C virus entry: Molecular biology and clinical implications
2006
Strategies for MMP inhibition in cancer: innovations for the post-trial era
2002
Cell entry of hepatitis C virus
2006
Intravascular Transfer Contributes to Postprandial Increase in Numbers of Very-Low-Density Hepatitis C Virus Particles
2010
Hepatitis C Virus Proteins: From Structure to Function
2013
RNA Interference and Single Particle Tracking Analysis of Hepatitis C Virus Endocytosis
2009
Hepatitis C virus host cell entry
2012
Apolipoprotein B–dependent hepatitis C virus secretion is inhibited by the grapefruit flavonoid naringenin
2008
Chapter 2 Cutting the Gordian Knot-Development and Biological Relevance of Hepatitis C Virus Cell Culture Systems
2008
Dendritic cells: emerging pharmacological targets of immunosuppressive drugs
2004
High Density Lipoprotein Inhibits Hepatitis C Virus-neutralizing Antibodies by Stimulating Cell Entry via Activation of the Scavenger Receptor BI
2006
A Serpin Shapes the Extracellular Environment to Prevent Influenza A Virus Maturation
2015 StandoutNobel
Mouse Hepatic Cells Support Assembly of Infectious Hepatitis C Virus Particles
2011
Intrinsic Immunity Shapes Viral Resistance of Stem Cells
2017 StandoutNobel
The emerging role of CTLA4 as a cell-extrinsic regulator of T cell responses
2011
The Humoral Immune Response to HCV: Understanding is Key to Vaccine Development
2014
The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage
1999 StandoutNatureNobel
The ins and outs of hepatitis C virus entry and assembly
2013 StandoutNobel
Hepatitis C Virus Subverts Liver-Specific miR-122 to Protect the Viral Genome from Exoribonuclease Xrn2
2014
Taking dendritic cells into medicine
2007 StandoutNatureNobel
Human occludin is a hepatitis C virus entry factor required for infection of mouse cells
2009 StandoutNatureNobel
Trafficking of Hepatitis C Virus Core Protein during Virus Particle Assembly
2011
Role of low-density lipoprotein receptor in the hepatitis C virus life cycle
2011
Oxidized low-density lipoprotein inhibits hepatitis C virus cell entry in human hepatoma cells
2006 StandoutNobel
Signals involved in thymocyte positive and negative selection
1999
Adaptation of Hepatitis C Virus to Mouse CD81 Permits Infection of Mouse Cells in the Absence of Human Entry Factors
2010
Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry
2007 StandoutNatureNobel
A diverse range of gene products are effectors of the type I interferon antiviral response
2011 StandoutNatureNobel
Genome-Scale Identification of SARS-CoV-2 and Pan-coronavirus Host Factor Networks
2020 StandoutNobel
Mechanisms and significance of liver steatosis in hepatitis C virus infection
2006
Virion Assembly and Release
2013
Production of Infectious Hepatitis C Virus in Primary Cultures of Human Adult Hepatocytes
2010
The Exchangeable Apolipoprotein ApoC-I Promotes Membrane Fusion of Hepatitis C Virus
2007
Structural biology of hepatitis C virus
2004
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
2014 Standout
Understanding the hepatitis C virus life cycle paves the way for highly effective therapies
2013 StandoutNobel
A Hepatitis C Virus (HCV) Vaccine Comprising Envelope Glycoproteins gpE1/gpE2 Derived from a Single Isolate Elicits Broad Cross-Genotype Neutralizing Antibodies in Humans
2013 StandoutNobel
Distinct Cellular Mechanisms Underlie Anti-CTLA-4 and Anti-PD-1 Checkpoint Blockade
2017 StandoutNobel
A genetically humanized mouse model for hepatitis C virus infection
2011 StandoutNatureNobel
Use of human hepatocyte-like cells derived from induced pluripotent stem cells as a model for hepatocytes in hepatitis C virus infection
2011
Novel Insights into Hepatitis C Virus Replication and Persistence
2004
Functional hepatitis C virus envelope glycoproteins
2004
Role of interferons in the regulation of cell proliferation, differentiation, and development
1994
TMEM41B Is a Pan-flavivirus Host Factor
2020 StandoutNobel
Endosomal proteolysis and MHC class II function
1998
Three-Dimensional Architecture and Biogenesis of Membrane Structures Associated with Hepatitis C Virus Replication
2012
HCV and the hepatic lipid pathway as a potential treatment target
2011
Proteomic approaches to uncovering virus–host protein interactions during the progression of viral infection
2016
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Replication of hepatitis C virus
2007 StandoutNobel
Hepatitis C Virus RNA Functionally Sequesters miR-122
2015 StandoutNobel
An in vitro model of hepatitis C virion production
2005
Apolipoprotein E Likely Contributes to a Maturation Step of Infectious Hepatitis C Virus Particles and Interacts with Viral Envelope Glycoproteins
2014
Genomic analysis of the host response to hepatitis C virus infection
2002
Phosphoinositides in the Hepatitis C Virus Life Cycle
2012
Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles
2003 StandoutNobel
Cellular Determinants of Hepatitis C Virus Assembly, Maturation, Degradation, and Secretion
2007
Reconstitution of the Entire Hepatitis C Virus Life Cycle in Nonhepatic Cells
2012
Structure and Function of the Hepatitis C Virus Envelope Glycoproteins E1 and E2: Antiviral and Vaccine Targets
2016 StandoutNobel
Hepatitis C Virus Envelope Glycoprotein E1 Forms Trimers at the Surface of the Virion
2015
Regulation of Hepatitis C Virus Translation and Infectious Virus Production by the MicroRNA miR-122
2010
Infectious Hepatitis C Virus Pseudo-particles Containing Functional E1–E2 Envelope Protein Complexes
2003
Cooperativity in Virus Neutralization by Human Monoclonal Antibodies to Two Adjacent Regions Located at the Amino Terminus of Hepatitis C Virus E2 Glycoprotein
2012
The low-density lipoprotein receptor plays a role in the infection of primary human hepatocytes by hepatitis C virus
2006
Characterization of the Envelope Glycoproteins Associated with Infectious Hepatitis C Virus
2010
Hepatitis C Virus Entry
2013
Ultrastructural analysis of hepatitis C virus particles
2013 StandoutNobel
Scavenger Receptor BI and BII Expression Levels Modulate Hepatitis C Virus Infectivity
2007
Pharmacological and surgical treatment of obesity.
2004
Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus
2012 StandoutNobel
Harnessing host–virus evolution in antiviral therapy and immunotherapy
2019
Monoclonal Antibody AP33 Defines a Broadly Neutralizing Epitope on the Hepatitis C Virus E2 Envelope Glycoprotein
2005
Role of Hypervariable Region 1 for the Interplay of Hepatitis C Virus with Entry Factors and Lipoproteins
2014
High-Avidity Monoclonal Antibodies against the Human Scavenger Class B Type I Receptor Efficiently Block Hepatitis C Virus Infection in the Presence of High-Density Lipoprotein
2007 StandoutNobel
Initiation of Hepatitis C Virus Infection Is Dependent on Cholesterol and Cooperativity between CD81 and Scavenger Receptor B Type I
2006
Establishment of B-Cell Lymphoma Cell Lines Persistently Infected with Hepatitis C Virus In Vivo and In Vitro: the Apoptotic Effects of Virus Infection
2003
Computational Prediction of the Heterodimeric and Higher-Order Structure of gpE1/gpE2 Envelope Glycoproteins Encoded by Hepatitis C Virus
2017 StandoutNobel
Hepatitis C Virus Evasion Mechanisms from Neutralizing Antibodies
2011
cis -Acting RNA Signals in the NS5B C-Terminal Coding Sequence of the Hepatitis C Virus Genome
2004
Interferon-Stimulated Genes: A Complex Web of Host Defenses
2014 StandoutNobel
Studying Hepatitis C Virus: Making the Best of a Bad Virus
2007 StandoutNobel
Hepatitis C virus entry: potential receptors and their biological functions
2006
Infectivity of Hepatitis C Virus Is Influenced by Association with Apolipoprotein E Isoforms
2010
Neutralizing Antibody-Resistant Hepatitis C Virus Cell-to-Cell Transmission
2010
Association between Hepatitis C Virus and Very-Low-Density Lipoprotein (VLDL)/LDL Analyzed in Iodixanol Density Gradients
2006
A Genetic Interaction between the Core and NS3 Proteins of Hepatitis C Virus Is Essential for Production of Infectious Virus
2011
Incorporation of Hepatitis C Virus E1 and E2 Glycoproteins: The Keystones on a Peculiar Virion
2014
Transport of Peptide-MHC Class II Complexes in Developing Dendritic Cells
2000 StandoutScienceNobel
Blocking HCV Entry as Potential Antiviral Therapy
2012
Cellular cofactors affecting hepatitis C virus infection and replication
2007 StandoutNobel
A cell protection screen reveals potent inhibitors of multiple stages of the hepatitis C virus life cycle
2010 StandoutNobel
Engrafted human stem cell–derived hepatocytes establish an infectious HCV murine model
2014
Neutralizing Antibody Response to Hepatitis C Virus
2011
The interaction of natural hepatitis C virus with human scavenger receptor SR‐BI/Cla1 is mediated by ApoB‐containing lipoproteins
2006
Role of the E2 Hypervariable Region (HVR1) in the Immunogenicity of a Recombinant Hepatitis C Virus Vaccine
2018 StandoutNobel
Human Apolipoprotein E Is Required for Infectivity and Production of Hepatitis C Virus in Cell Culture
2007
Successful anti-scavenger receptor class B type I (SR-BI) monoclonal antibody therapy in humanized mice after challenge with HCV variants with in vitro resistance to SR-BI-targeting agents
2014 StandoutNobel
Extracellular Interactions between Hepatitis C Virus and Secreted Apolipoprotein E
2017
Virus‐neutralizing antibodies to hepatitis C virus
2013
Hepatitis C Virus Hypervariable Region 1 Modulates Receptor Interactions, Conceals the CD81 Binding Site, and Protects Conserved Neutralizing Epitopes
2010
Hepatitis C Virus Glycoproteins Interact with DC-SIGN and DC-SIGNR
2003 StandoutNobel
Hepatitis C Virus: Evading the Intracellular Innate Immunity
2020
Apolipoprotein C1 Association with Hepatitis C Virus
2008
Mutations in Hepatitis C Virus E2 Located outside the CD81 Binding Sites Lead to Escape from Broadly Neutralizing Antibodies but Compromise Virus Infectivity
2009 StandoutNobel
Genetic and Functional Characterization of the N-Terminal Region of the Hepatitis C Virus NS2 Protein
2013 StandoutNobel
The Multifaceted Roles of Autophagy in Flavivirus-Host Interactions
2018
Hepatitis C virus production by human hepatocytes dependent on assembly and secretion of very low-density lipoproteins
2007
Characterization of Hepatitis C Virus Interaction with Heparan Sulfate Proteoglycans
2015
Identification of a Residue in Hepatitis C Virus E2 Glycoprotein That Determines Scavenger Receptor BI and CD81 Receptor Dependency and Sensitivity to Neutralizing Antibodies
2008
Ultrastructural and Biophysical Characterization of Hepatitis C Virus Particles Produced in Cell Culture
2010
Function of PI3Kγ in Thymocyte Development, T Cell Activation, and Neutrophil Migration
2000 StandoutScienceNobel
Medullary Thymic Epithelium: A Mosaic of Epithelial “Self”?
1998
Different Requirements for Scavenger Receptor Class B Type I in Hepatitis C Virus Cell-Free versus Cell-to-Cell Transmission
2013 StandoutNobel
Differential Biophysical Properties of Infectious Intracellular and Secreted Hepatitis C Virus Particles
2006
Apolipoprotein E but Not B Is Required for the Formation of Infectious Hepatitis C Virus Particles
2009
Hypervariable Region 1 Differentially Impacts Viability of Hepatitis C Virus Strains of Genotypes 1 to 6 and Impairs Virus Neutralization
2010
Targeting HCV Entry For Development of Therapeutics
2010
Structure of the catalytic domain of the hepatitis C virus NS2-3 protease
2006 StandoutNatureNobel
Works of Patrice André being referenced
Viruses and Interactomes in Translation
2012
Assembly of infectious hepatitis C virus particles
2010
VirHostNet: a knowledge base for the management and the analysis of proteome-wide virus–host interaction networks
2008
Flavivirus NS3 and NS5 proteins interaction network: a high-throughput yeast two-hybrid screen
2011
Hepatitis C Virus Particles and Lipoprotein Metabolism
2005
An embryonic DNA-binding protein specific for a region of the human IFN 1, promoter
1988
High plasma level of nucleocapsid-free envelope glycoprotein-positive lipoproteins in hepatitis C patients
2012
IRGM Is a Common Target of RNA Viruses that Subvert the Autophagy Network
2011
Virus-host interactomics: new insights and opportunities for antiviral drug discovery
2014
Biochemical and Morphological Properties of Hepatitis C Virus Particles and Determination of Their Lipidome
2010
Enhancement of genotype 1 hepatitis C virus replication by bile acids through FXR
2007
Selectivity of the major histocompatibility complex class II presentation pathway of cortical thymic epithelial cell lines
1997
New horizons for antiviral drug discovery from virus–host protein interaction networks
2012
Morphological Characterization and Fusion Properties of Triglyceride-rich Lipoproteins Obtained from Cells Transduced with Hepatitis C Virus Glycoproteins
2010
Secretion of Hepatitis C Virus Envelope Glycoproteins Depends on Assembly of Apolipoprotein B Positive Lipoproteins
2009
Hepatitis E virus mutations associated with ribavirin treatment failure result in altered viral fitness and ribavirin sensitivity
2016
Strand specific quantitative real-time PCR to study replication of hepatitis C virus genome
2003
Automated quantitative determination of hepatitis C virus viremia by reverse transcription-PCR
1994
An inhibitor of HIV-1 protease modulates proteasome activity, antigen presentation, and T cell responses
1998
Preferential association of Hepatitis C virus with apolipoprotein B48-containing lipoproteins
2006
1-Methyl-Tryptophan Can Interfere with TLR Signaling in Dendritic Cells Independently of IDO Activity
2006
Effect of weight change and metformin on fibrinolysis and the von Willebrand factor in obese nondiabetic subjects: the BIGPRO1 Study. Biguanides and the Prevention of the Risk of Obesity.
1998
Expression of hepatitis C virus proteins in epithelial intestinal cells in vivo
2004
Characterization of Low- and Very-Low-Density Hepatitis C Virus RNA-Containing Particles
2002
A dominant-negative mutant of the Rab5 GTPase enhances T cell signaling by interfering with TCR down-modulation in transgenic mice.
1997
Hepatitis C Virus Infection Protein Network
2008